Study Examines Multiple Methods of Testing Driving Impairment after Consuming Cannabis
A recent study reported results from a University of California San Diego Center for Medicinal Cannabis Research study on cannabis consumption and its effects on driving ability.
A study published May 25, 2023 in the journal Clinical Chemistry evaluated the effects of tetrahydrocannabinol (THC) on driving performance (1). The placebo-controlled randomized double-blinded protocol studied 191 participants who were instructed to smoke as much or as little of a THC cigarette that was either a placebo or contained delta-9-tetrahydrocannabinol (1).
“The relationship between blood THC concentrations and crash risk is not established, but there is a clear understanding that THC impairs driving performance in many, but not necessarily all, individuals,” the introduction stated (1). “The question that remains is how to best identify drivers who are impaired by cannabis.”
After smoking, the participants gave blood, oral fluids (OF), and breath samples. Law enforcement officers from the California Highway Patrol or other agencies performed the sobriety tests on the participants and classified them as impaired or not impaired.
“In the largest trial to date involving experienced users smoking cannabis, there was no correlation between THC (and related metabolites/cannabinoids) in blood, OF, or breath and driving performance,” the researchers concluded (1). “Our data support the current practice in many areas of the United States that requires officer observations of impairment along with toxicology testing before prosecuting drivers for being under the influence.”
The researchers suggested evidence for using oral fluids as opposed to blood samples in reducing the likelihood of false accusations of impairment, and stated that more research is needed on the comparison between exams from drug recognitions experts and field sobriety tests (1).
Reference
- Fitzgerald, R. L.; Umlauf, A.; Hubbard, J. A.; Hoffman, M. A.; Sobolesky, P. M.; Ellis, S. E.; Grelotti, D. J.; Suhandynata, R. T.; Huestis, M. A.; Grant, I.; Marcotte, T. D. Driving under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests. Clinical Chemistry 2023.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Khan
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
